Concord Medical Services ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $65.9M+25.2% YoYTTM through 31 Dec 2025
Net Income -$13.3MTTM through 31 Dec 2025
Free Cash Flow -$36.9MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 5.6% |
| EBITDA Margin | -26.5% |
| Operating Margin | -56.8% |
| Net Margin | -20.2% |
Returns
7.5%ROE
-5.6%ROA
Balance Sheet Health
Debt / Equity1.96x
Current Ratio0.48x
Net Debt$3.2B
Cash & Equivalents$42.6M
Quality Metrics
Altman Z-Score-1.19
Piotroski F-Score6 / 9
FCF Margin-56.1%
Multi-Year Trend
RevenueFY2025: $460.5M
Diluted EPS-$0.10TTMFY2025: $-0.71
Dividend
No dividend
Capital Allocation
Capex Intensity12.2%
Segment Performance
No segment data available.
Financials converted at 6.9961 from RMB.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.